Your browser doesn't support javascript.
loading
OnabotulinumtoxinA Improves Quality of Life in Chronic Migraine: The PREDICT Study - CORRIGENDUM.
Boudreau, Guy; Finkelstein, Ian; Graboski, Corrie; Ong, May; Christie, Suzanne; Sommer, Katherine; Bhogal, Meetu; Davidovic, Goran; Becker, Werner J.
Affiliation
  • Boudreau G; Centre Hospitalier Universitaire de Montréal (CHUM), Montréal, Quebec, Canada.
  • Finkelstein I; Toronto Headache & Pain Clinic, Toronto, Ontario, Canada.
  • Graboski C; Island Health, Brentwood Bay, British Columbia, Canada.
  • Ong M; St Paul Hospital, Vancouver, British Columbia, Canada.
  • Christie S; University of Ottawa (Neurology), Ottawa, Ontario, Canada.
  • Sommer K; AbbVie Inc., Marlow, Buckinghamshire, UK.
  • Bhogal M; AbbVie Inc., Markham, Ontario, Canada.
  • Davidovic G; AbbVie Inc., Markham, Ontario, Canada.
  • Becker WJ; Department of Clinical Sciences, University of Calgary, Calgary, Alberta, Canada.
Can J Neurol Sci ; 51(1): 149, 2024 Jan.
Article in En | MEDLINE | ID: mdl-38105013
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Botulinum Toxins, Type A / Migraine Disorders Limits: Humans Language: En Journal: Can J Neurol Sci Year: 2024 Document type: Article Affiliation country: Canada
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Botulinum Toxins, Type A / Migraine Disorders Limits: Humans Language: En Journal: Can J Neurol Sci Year: 2024 Document type: Article Affiliation country: Canada